Mesa Laboratories (NASDAQ:MLAB) SVP Brian David Archbold Sells 1,151 Shares of Stock

Mesa Laboratories, Inc. (NASDAQ:MLAB) SVP Brian David Archbold sold 1,151 shares of the firm’s stock in a transaction dated Tuesday, June 16th. The shares were sold at an average price of $101.27, for a total value of $116,561.77. Following the sale, the senior vice president owned 3,710 shares of the company’s stock, valued at $375,711.70. This represents a 23.68% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Mesa Laboratories Stock Down 4.7%

Shares of Mesa Laboratories stock opened at $94.95 on Thursday. The business has a 50-day moving average of $101.90 and a 200-day moving average of $90.64. The company has a debt-to-equity ratio of 0.78, a current ratio of 1.72 and a quick ratio of 1.29. The company has a market capitalization of $524.12 million, a PE ratio of 79.13 and a beta of 0.94. Mesa Laboratories, Inc. has a 1-year low of $55.45 and a 1-year high of $113.99.

Mesa Laboratories (NASDAQ:MLAB) last announced its earnings results on Wednesday, May 27th. The medical instruments supplier reported $1.53 earnings per share for the quarter, missing the consensus estimate of $1.78 by ($0.25). The business had revenue of $63.72 million for the quarter, compared to analyst estimates of $65.21 million. Mesa Laboratories had a net margin of 2.69% and a return on equity of 20.96%. During the same quarter in the prior year, the business earned ($1.31) earnings per share.

Mesa Laboratories Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Monday, June 15th. Stockholders of record on Friday, May 29th were paid a dividend of $0.16 per share. The ex-dividend date was Friday, May 29th. This represents a $0.64 annualized dividend and a dividend yield of 0.7%. Mesa Laboratories’s dividend payout ratio (DPR) is currently 53.33%.

Hedge Funds Weigh In On Mesa Laboratories

Several large investors have recently modified their holdings of MLAB. Northwestern Mutual Wealth Management Co. lifted its position in shares of Mesa Laboratories by 5,366.7% during the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 328 shares of the medical instruments supplier’s stock worth $26,000 after purchasing an additional 322 shares during the last quarter. Caitong International Asset Management Co. Ltd bought a new position in shares of Mesa Laboratories during the fourth quarter worth about $27,000. Kestra Advisory Services LLC bought a new position in shares of Mesa Laboratories during the fourth quarter worth about $55,000. BNP Paribas Financial Markets lifted its position in shares of Mesa Laboratories by 30.9% during the third quarter. BNP Paribas Financial Markets now owns 1,029 shares of the medical instruments supplier’s stock worth $69,000 after purchasing an additional 243 shares during the last quarter. Finally, Tower Research Capital LLC TRC lifted its position in shares of Mesa Laboratories by 432.9% during the second quarter. Tower Research Capital LLC TRC now owns 842 shares of the medical instruments supplier’s stock worth $79,000 after purchasing an additional 684 shares during the last quarter. Institutional investors own 90.60% of the company’s stock.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings cut shares of Mesa Laboratories from a “sell (d+)” rating to a “sell (d)” rating in a research report on Wednesday, June 3rd. Two investment analysts have rated the stock with a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Reduce” and a consensus price target of $94.00.

Mesa Laboratories Company Profile

Mesa Laboratories, Inc (NASDAQ: MLAB) is a global provider of instrumentation products designed for critical process monitoring, testing and calibration. Headquartered in Lakewood, Colorado, the company serves a diverse set of end markets including healthcare, pharmaceutical, food and beverage, energy and industrial sectors. With a focus on precision measurement and validation, Mesa Laboratories helps customers ensure regulatory compliance, product safety and operational efficiency across complex manufacturing and sterilization processes.

The company’s product portfolio encompasses biological and chemical indicators for sterilization process validation, digital data loggers and sensors for environmental monitoring, and optical gas analyzers with sample-conditioning solutions for oil, gas and petrochemical applications.